Subsequent Kaplan-Meier analysis of patients with cervical carcinoma from GEPIA demonstrated that patients with high HMGB1 expression levels displayed significantly poorer overall survival (p = 0.029) and disease free survival (p = 0.012) than those with low HMGB1 expression levels (Fig. 5c). This evidence concerns the gene HMGB1 and cervical carcinoma.